| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (403kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-460089
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.46008
Zusammenfassung
Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only potentially curative treatment option for many patients with hematological disorders but it includes a significant risk of mortality and long-term morbidity. Many patients and their support persons feel overwhelmed when being informed about alloHSCT and may benefit from improvements in consultation style and ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags